B-lymphocytes in CLL and NHL differ in the mRNA splicing pattern of the CD45 molecule

European Journal of Haematology

Volumn 64, Issue 6, 2000, Pages 376-384

  Yu, Y ^a   Rabinowitz, R ^a   Polliack, A ^b   Ben Bassat, H ^b   Schlesinger, Michael ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

CD45 isoforms; CD45 mRNA; CLL; NHL

Indexed keywords

CD45 ANTIGEN;

ARTICLE; B LYMPHOCYTE; CELL HETEROGENEITY; CELL LINE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; NONHODGKIN LYMPHOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RNA SPLICING;

ANTIGENS, CD45; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA, NON-HODGKIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; RNA, MESSENGER; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0033934947     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2000.90144.x     Document Type: Article

References (29)

1. 1. CSANAKY G, MATUTES E, VASS JA, MORILLA R, CATOVSKY D. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias. Leukemia 1997;11: 408-415.
2. 2. RABINOWITZ R, POLLIACK A, KEREN-ZUR Y, LEIZEROWITZ R, SCHLESINGER M. Expression of CD11a (LFA-1) on chronic lymphocytic leukemia and lymphoma cells. Correlation with cell surface immunoglobulin intensity and CD58 (LFA-3) expression. Leukemia Lymphoma 1991;Suppl 5: 59-64.
3. 3. CRIEL A, VERHOEF G, VLIETINCK R, et al. Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases. Br J Haematol 1997;97:383-391.
4. 4. MATUTES E, OSCIER D, GARCIA-MARCO J, et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996;92:382-388.
5. 5. ZOMAS AP, MATUTES E, MORILLA R, OWUSU-ANKOMAH K, SEON BK, CATOVSKY D. Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). Leukemia 1996;10: 1966-1970.
6. 6. THOMPSON AA, TALLEY JA, DO HN, et al. Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. Blood 1997;90:1387-1394.
7. 7. SU'UT L, O'CONNOR SJM, RICHARDS SJ, et al. Trisomy 12 is seen within a specific subtype of B-cell chronic lymphoproliferative disease affecting the peripheral blood/bone marrow and co-segregates with elevated expression of CD11a. Br J Haematol 1998;101:165-170.
8. 8. TROWBRIDGE IS, THOMAS ML. CD45: An emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Ann Rev Immunol 1994;12:85-116.
9. 9. SMITH SH, BROWN MH, ROWE D, CALLARD RE, BEVERLEY PCL. Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunol 1986;58:63-70.
10. 10. AKBAR AN, TIMMS A, JANOSSY G. Cellular events during memory T-cell activation in vitro: the UCHL1 (180,000 MW) determinant is newly synthesized after mitosis. Immunol 1989;66:213-218.
11. 11. ZOLA H, MACARDLE PJ, FLEGO L, WEBSTER J. The expression of subpopulation markers on B cells: A re-evaluation using high-sensitivity fluorescence flow cytometry. Disease Markers 1991;9:103-118.
12. - B lymphocyte subset producing natural antibodies. J Immunol 1992;148: 2690-2702.
13. + monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood 1991;78:711-719.
14. 14. ROSENMANN E, RABINOWITZ R, SCHLESINGER M. Lymphocyte subsets in human tonsils: The effect of age and infection. Pediatr Allergy Immunol 1998;9:161-167.
15. 15. JENSEN GS, POPPEMA S, MANT MJ, PILARSKI LM. Transition in CD45 isoform expression during differentiation of normal and abnormal B cells. Int Immunol 1989;1:229-236.
16. 16. ZOLA H. , Melo JV, Zowtyj HN, Nikoloutsopoulos A, Skinner J. The leukocyte-common antigen (CD45) complex and B-lymphocyte activation. Human Immunol 1990;27: 368-377.
17. 17. ROXBURGH AE, COOPER IA. Expression of leucocyte-common antigen and large sialoglycoprotein on leukemic cells in B-cell chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Leukemia Res 1987;11:891-901.
18. 18. CALDWELL CW, MARTY LM, FELDBUSH TL. Expression of the low Mr isoform of CD45 (CD45RO) in B-cell non-Hodgkin's lymphomas. Clin Immunol Immunopathol 1991;58:377-384.
19. 19. ZOLA H, SIDERIUS N, FLEGO L, et al. Expression of CD45 isoforms in chronic B-cell leukaemias. Leukemia Res 1993;17:209-216.
20. 20. MADDY A, SANDERSON A, MACKIE MJ, SMITH SK. The role of cell maturation in the generation of phenotypic heterogeneity in B-cell chronic lymphocytic leukemia. Immunol 1989;68:346-352.
21. 21. SHUBINSKY G, BEN-BASSAT H, SCHLESINGER M. The effect of IL-4 on the phenotype of human B-cell lymphoma line (Farage) lacking immunoglobulin expression. Immunol Lett 1993;36:37-42.
22. 22. HARRIS NL, JAFFE ES, STEIN H, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1391.
23. 23. International Workshop on CLL. Chronic lymphocytic leukemia: Recommendations for diagnosis, staging and response criteria. Ann Internal Med 1989;110:236-238.
24. 24. RABINOWITZ R, POKROY R, YU Y, SCHLESINGER M. Activated Human T-cells bestow T-cell antigens to non-T-cells by intercellular antigen transfer. Human Immunol 1998;59: 331-342.
25. 25. RATECH H, DENNING S, KAUFMAN RE. An analysis of alternatively spliced CD45 mRNA transcripts during T cell maturation in humans. Cell Immunol 1997;177:109-118.
26. 26. SAGA Y, LEE JS, BOYSE EA. Regulation of alternative splicing in the generation of isoforms of the mouse Ly-5 (CD45) glycoprotein. Proc Natl Acad Sci 1990;87: 3728-3732.
27. 27. ROTHSTEIN DM, SAITO H, STREULI M, SCHLOSSMAN SF, MORIMOTO C. The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory transacting splicing factors. J Biol Chem 1992;267:7139-7147.
28. 28. MARTY LM, CALDWELL CW, FELDBUSH TL. Expression of CD45 isoforms by Epstein-Barr virus-transformed human B lymphocytes. Clin Immunol Immunopathol 1992;62: 8-15.
29. 29. KLEIN U, GOOSENS T, FISCHER M, et al. Somatic hypermutation in normal and transformed human B cells. Immunol Rev 1998;162:261-280.